27 research outputs found
Lesioni non palpabili della mammella: la Mammotome-biopsy nella gestione preoperatoria del cancro della mammella
Premessa: Il tumore del seno è nei paesi occidentali al primo posto per frequenza nelle donne e la sua incidenza è in costante crescita. Grazie soprattutto
alla diffusione dello screening mammografico e ad una maggiore consapevolezza
del problema, negli ultimi anni è aumentata la diagnosi delle cosiddette lesioni
“non palpabili”; parimenti si è assistito ad un importante sviluppo delle metodiche diagnostiche di tipo mininvasivo. Alla tradizionale citologia con ago sottile si sono affiancate infatti varie procedure bioptiche percutanee; tali metodiche
microistologiche hanno quasi del tutto sostituito la biopsia chirurgica escissionale e l’esame intra-operatorio al congelatore.
Pazienti e metodo: Nella nostra Divisione di Chirurgia Generale,
Vascolare e Mininvasiva, dal dicembre 1999 al settembre 2004 abbiamo eseguito, in collaborazione con il servizio di Radiologia, 214 biopsie su guida ecografia utilizzando la vacuum-assisted biopsy (Mammotome®
) con ago 11-Gauge. I
risultati ottenuti per ciò che concerne l’accuratezza diagnostica, la quantità e
qualitĂ delle informazioni ottenute, il significato delle stesse nella eventuale
gestione chirurgica, il discomfort globale per la paziente sono stati analizzati e
discussi nel presente lavoro.
Risultati: Delle 214 biopsie eseguite con tecnica Mammotome,
nell’89,3% dei casi si è trattato di lesioni clinicamente non palpabili, con un
diametro medio di 8 mm. L’età media delle pazienti era di 57,6 anni (range
31-88). La positività per patologia maligna è stata di 90 casi (42%). Nei casi
di iperplasia duttale atipica e radial scar (6%) è stata effettuata l’exeresi chirurgica della lesione che ha confermato nel 100% dei casi la precedente diagnosi bioptica. Il 19% delle pazienti sottoposte a biopsia Mammotome era stato
precedentemente sottoposto ad un prelievo citologico con ago sottile.
Confrontando i risultati delle due metodiche, l’attendibilità diagnostica della
seconda risulta essere significativamente superiore (p<0,05) come pure il numero di informazioni ottenute (istotipo, invasivitĂ , grading, recettori ormonali,
etc.); il discomfort legato alla procedura, valutato in termini di dolore (VAS),
è risultato inferiore a quello del prelievo con ago sottile (p<0,05). L’unica complicanza della biopsia Mammotome è rappresentata dall’ematoma nella sede
del prelievo (8% dei casi). Il numero dei falsi negativi è stato di un caso, dovuto
ad un non corretto centraggio del bersaglio.
Conclusioni: Allo stato attuale in presenza di una lesione non palpabile
della mammella la scelta della metodica diagnostica (agobiopsia o
Mammotome) è legata al sospetto radiologico nella prospettiva di un eventuale
intervento chirurgico. La biopsia con Mammotome nelle lesioni non palpabil
MILS in a general surgery unit: learning curve, indications, and limitations
Minimally invasive liver surgery (MILS) is going to be a method with a wide diffusion even in general surgery units. Organization, learning curve effect, and the environment are crucial issues to evaluate before starting a program of minimally invasive liver resections. Analysis of a consecutive series of 70 patients has been used to define advantages and limits of starting a program of MILS in a general surgery unit. Seventeen MILS have been calculated with the cumulative sum method as the number of cases to complete the learning curve. Operative times [270 (60-480) vs. 180 (15-550) min; p 0.01] and rate of conversion (6/17 vs. 5/53; p 0.018) decrease after this number of cases. More complex cases can be managed after a proper optimization of all steps of liver resection. When a high confidence of the medical and nurse staff with MILS is reached, economical and strategic issues should be evaluated in order to establish a multidisciplinary hepatobiliary unit independent from the general surgery unit to manage more complex cases
Tumorectomy
The treatment of liver diseases comprises a significant component of the practice of any general surgeon, whether working in an academic, a general, or a community hospital. With the rapid expansion in knowledge and technology, the liver has also been approached laparoscopically in specialized centers, with well-recognized advantages for patients. This book aims to communicate the large body of experience that has now been accumulated in minimally invasive liver surgery, with comprehensive and up-to-date information on the newest techniques. After a concise description of the main tools and technology necessary to carry out safe laparoscopic and/or robot-assisted liver surgery, individual operative techniques are explained and illustrated. Each chapter includes introductory information, a summary of indications and contraindications, and a detailed description of surgical procedure, including potential complications of both the surgery and the postoperative care. Special efforts have been taken to ensure that the illustrations are accurate and informative. The text is supplemented by a DVD of different procedures as performed by leading European liver surgeons
Non-cirrhotic liver tolerance to intermittent inflow occlusion during laparoscopic liver resection
While inflow occlusion techniques are accepted methods to reduce bleeding during open liver surgery, their use in laparoscopic liver resections are limited by possible effects of pneumoperitoneum on ischemia-reperfusion liver damage. This retrospective study was designed to investigate the impact of intermittent pedicle clamping (IPC) on patients with normal liver undergoing minor laparoscopic liver resections. Three matched groups of patients were retrospectively selected from our in-house database: 11 patients who underwent robot-assisted liver resection with IPC, and 16 and 11 patients who underwent robot-assisted liver resection without IPC and open liver resection with IPC, respectively. The primary end point was to assess differences in postoperative serum alanine, aspartate aminotransferase (ALT and AST) and bilirubin levels. The curves of serum AST, ALT and bilirubin levels in a span of time of five postoperative days were not significantly different between the three groups. IPC has no relevant effects on ischemia-reperfusion liver damage even in the presence of pneumoperitoneum. © 2011 Springer-Verlag
Robotic-assisted transperitoneal nephron-sparing surgery for small renal masses with associated surgical procedures: surgical technique and preliminary experience
Small renal masses (T1a) are commonly diagnosed incidentally and can be treated with nephron-sparing surgery, preserving renal function and obtaining the same oncological results as radical surgery. Bigger lesions (T1b) may be treated in particular situations with a conservative approach too. We present our surgical technique based on robotic assistance for nephron-sparing surgery. We retrospectively analysed our series of 32 consecutive patients (two with 2 tumours and one with 4 bilateral tumours), for a total of 37 robotic nephron-sparing surgery (RNSS) performed between June 2008 and July 2012 by a single surgeon (G.C.). The technique differs depending on tumour site and size. The mean tumour size was 3.6 cm; according to the R.E.N.A.L. Nephrometry Score 9 procedures were considered of low, 14 of moderate and 9 of hight complexity with no conversion in open surgery. Vascular clamping was performed in 22 cases with a mean warm ischemia time of 21.5 min and the mean total procedure time was 149.2 min. Mean estimated blood loss was 187.1 ml. Mean hospital stay was 4.4 days. Histopathological evaluation confirmed 19 cases of clear cell carcinoma (all the multiple tumours were of this nature), 3 chromophobe tumours, 1 collecting duct carcinoma, 5 oncocytomas, 1 leiomyoma, 1 cavernous haemangioma and 2 benign cysts. Associated surgical procedures were performed in 10 cases (4 cholecystectomies, 3 important lyses of peritoneal adhesions, 1 adnexectomy, 1 right hemicolectomy, 1 hepatic resection). The mean follow-up time was 28.1 months ± 12.3 (range 6-54). Intraoperative complications were 3 cases of important bleeding not requiring conversion to open or transfusions. Regarding post-operative complications, there were a bowel occlusion, 1 pleural effusion, 2 pararenal hematoma, 3 asymptomatic DVT (deep vein thrombosis) and 1 transient increase in creatinine level. There was no evidence of tumour recurrence in the follow-up. RNSS is a safe and feasible technique. Challenging situations are hilar, posterior or intraparenchymal tumour localization. In our experience, robotic technology made possible a safe minimally invasive management, including vascular clamping, tumour resection and parenchyma reconstruction